Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01515384 · ClinicalTrials.gov registry record · Phase 1

A Trial of 18F-AV-133 Positron Emission Tomography (PET)

A Phase 1 study, sponsored by Avid Radiopharmaceuticals.

Terminated
Registry status
Phase 1
Development phase
19
Enrollment target

NCT01515384: Clinical Trial Phase 1 study, sponsored by Avid Radiopharmaceuticals.

NCT01515384 is a Phase 1 study that was terminated before completion, run by Avid Radiopharmaceuticals. The registered enrollment target is 19 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01515384, a Phase 1 study, was terminated before completion, sponsored by Avid Radiopharmaceuticals.

TERMINATED
Registry status
Phase 1
Development phase
19 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the safety and pancreas imaging properties of 18F-AV-133.

Primary Outcome

SUVR=standard uptake value ratio

Interventions

  • DRUG 18F-AV-133

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2010-06
Est. Completion 2013-02
Phase Phase 1
Avid Radiopharmaceuticals

42 total trials

Why NCT01515384 stopped before completion

NCT01515384 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (68% lower).

The record links to 0 conditions, and to 1 intervention - of which 18F-AV-133 is the first listed.

NCT01515384 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01515384 about?

NCT01515384 is a clinical study titled "A Trial of 18F-AV-133 Positron Emission Tomography (PET)". The purpose of this study is to evaluate the safety and pancreas imaging properties of 18F-AV-133.

What is the current status of trial NCT01515384?

This trial is currently terminated. It is a Phase 1 study. The enrollment target is 19 participants. The study started on 2010-06. Estimated completion is 2013-02.

What interventions are being tested in trial NCT01515384?

The interventions under investigation include: 18F-AV-133 (DRUG).

Who is sponsoring clinical trial NCT01515384?

This trial is sponsored by Avid Radiopharmaceuticals, which has 42 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01515384's enrollment target sits among peer trials

19 1716th of 2000 higher than 281 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03207464 · 19 participants · Phase 1

    Molecular Imaging of NET Using [C-11]MRB-PET in MS

  • NCT04318717 · 19 participants · Phase 2

    Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma

  • NCT05103904 · 19 participants · Phase 2

    Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

  • NCT05607407 · 19 participants · Phase 2

    Methimazole in Patients With Progressive Glioblastoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01515384, the US trial registry maintained by the National Library of Medicine. NCT01515384 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.